Bank Julius Baer & Co
IBB icon

Bank Julius Baer & Co’s iShares Biotechnology ETF IBB Stock Holding History

Bank Julius Baer & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,083
Closed -$517K – 686
2025
Q2 		$517K Sell
4,083
-898
-18% -$110K ﹤0.01% 378
2025
Q1 		$637K Sell
4,981
-97,916
-95% -$13.3M ﹤0.01% 343
2024
Q4 		$15M Sell
102,897
-2,074
-2% -$292K 0.05% 177
2024
Q3 		$18.1M Sell
104,971
-6,747
-6% -$976K 0.06% 137
2024
Q2 		$17.1M Sell
111,718
-175,042
-61% -$23.4M 0.07% 129
2024
Q1 		$39.3M Sell
286,760
-2,937
-1% -$401K 0.15% 99
2023
Q4 		$39.4M Sell
289,697
-3,400
-1% -$415K 0.17% 103
2023
Q3 		$35.8M Buy
293,097
+10,542
+4% +$1.34M 0.21% 91
2023
Q2 		$35.9M Sell
282,555
-5,904
-2% -$767K 0.21% 92
2023
Q1 		$37.3M Buy
288,459
+6,081
+2% +$796K 0.24% 96
2022
Q4 		$37.1M Buy
282,378
+6,368
+2% +$823K 0.25% 87
2022
Q3 		$32.3M Buy
276,010
+85,145
+45% +$10.6M 0.25% 86
2022
Q2 		$22.5M Buy
190,865
+171,832
+903% +$20.4M 0.16% 99
2022
Q1 		$2.48M Sell
19,033
-168,723
-90% -$22M 0.01% 207
2021
Q4 		$28.7M Sell
187,756
-3,490
-2% -$540K 0.15% 102
2021
Q3 		$30.9M Buy
191,246
+16,153
+9% +$2.72M 0.19% 90
2021
Q2 		$28.7M Buy
175,093
+2,215
+1% +$341K 0.18% 101
2021
Q1 		$26M Sell
172,878
-302
-0.2% -$48K 0.19% 100
2020
Q4 		$26.2M Buy
173,180
+857
+0.5% +$122K 0.22% 86
2020
Q3 		$23.3M Sell
172,323
-1,939
-1% -$263K 0.23% 83
2020
Q2 		$24.3M Sell
174,262
-2,069
-1% -$264K 0.28% 77
2020
Q1 		$19M Buy
+176,331
New +$20.3M 0.44% 63

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank Julius Baer & Co's IBB Position: Q3 2025 in Review

Bank Julius Baer & Co sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 4,083 shares — an estimated $517K sold.

Bank Julius Baer & Co first reported a position in IBB in Q1 2020 and held it in 22 quarters. The position peaked at $39.4M in Q4 2023. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Bank Julius Baer & Co reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Bank Julius Baer & Co sold 4,083 iShares Biotechnology ETF shares in Q3 2025, an estimated $517K.
  • Bank Julius Baer & Co first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 22 quarters.
  • Bank Julius Baer & Co's iShares Biotechnology ETF position peaked at $39.4M in Q4 2023.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Bank Julius Baer & Co's 13F filing for Q3 2025, filed 13 Nov 2025.